These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 20645431)

  • 41. A non-immunological phospholipid-dependent coagulation inhibitor associated with IgGlambda-type multiple myeloma.
    Takamiya O; Machida S; Okuda M; Nojima J; Koreeda C; Kubara K
    Am J Hematol; 2004 Jan; 75(1):34-9. PubMed ID: 14695630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of lupus anticoagulant in the second-generation assay for activated protein C resistance.
    Ragland BD; Reed CE; Eiland BM; Tichenor PH; Hudson CL; Fritsma GA; Adler BK; Marques MB
    Am J Clin Pathol; 2003 Jan; 119(1):66-71. PubMed ID: 12520699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical diagnosis of thrombosis and blood coagulation tests].
    Watanabe K
    Rinsho Byori; 1998 Mar; 46(3):235-44. PubMed ID: 9564763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Consulting work performed by the hospital laboratory. Laboratory information from the screening test of blood coagulation].
    Komiyama Y; Yoshika M; Takahashi H
    Rinsho Byori; 2005 Jun; 53(6):514-21. PubMed ID: 16026078
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Filtered plasma as a potential cause of clinical misdiagnosis: inappropriate testing in a haematology laboratory.
    Favaloro EJ; Mohammed A; Coombs R; Mehrabani PA
    Br J Biomed Sci; 1995 Dec; 52(4):243-8. PubMed ID: 8555777
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new dilution for the modified APTT-based assay for activated protein C resistance: improvement of the reliability in patients with a lupus anticoagulant.
    Benattar N; Schved JF; Biron-Andréani C
    Thromb Haemost; 2000 Jun; 83(6):967-8. PubMed ID: 10896260
    [No Abstract]   [Full Text] [Related]  

  • 47. Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature.
    Vivaldi P; Rossetti G; Galli M; Finazzi G
    Haematologica; 1997; 82(3):345-7. PubMed ID: 9234588
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants.
    Alving BM; Baldwin PE; Richards RL; Jackson BJ
    Thromb Haemost; 1985 Oct; 54(3):709-12. PubMed ID: 3937268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coagulation mixing studies: Utility, algorithmic strategies and limitations for lupus anticoagulant testing or follow up of abnormal coagulation tests.
    Favaloro EJ
    Am J Hematol; 2020 Jan; 95(1):117-128. PubMed ID: 31674066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lupus anticoagulant assays: questions answered and to be answered.
    Teruya J; West AG; Suell MN
    Arch Pathol Lab Med; 2007 Jun; 131(6):885-9. PubMed ID: 17550315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Testing lupus anticoagulants in a real-life scenario - a retrospective cohort study.
    Ratzinger F; Panic T; Haslacher H; Perkmann T; Schmetterer KG; Belik S; Maenner G; Pabinger I; Quehenberger P
    Biochem Med (Zagreb); 2017 Oct; 27(3):030705. PubMed ID: 28900368
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of heparin in samples submitted for lupus anticoagulant testing.
    Sangle NA; Rodgers GM; Smock KJ
    Lab Hematol; 2011 Mar; 17(1):6-11. PubMed ID: 21421539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Chinese Boy With Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Case Report and Review of the Literature.
    Chan EY; Leung KFS; Soo ETL; Ma ALT
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):e445-e447. PubMed ID: 32287097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current practices for lupus anticoagulant testing at a tertiary care hospital and impact on laboratory resources.
    Aljabry MS
    Ann Saudi Med; 2015; 35(5):383-6. PubMed ID: 26506972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concomitant lupus anticoagulant and monoclonal IgMκ antibody in a patient with bleeding tendency: a case report and literature review.
    Alyanakian MA; Okada H; Bachelot-Loza C; Tournoux P; Varet B; Lasne D
    Am J Hematol; 2011 Oct; 86(10):868-71. PubMed ID: 22022726
    [No Abstract]   [Full Text] [Related]  

  • 56. Factor VIII inhibitor-tests could be less sensitive than supposed.
    Barthels M; Kraus M; Bohn U; Liese B; von Depka M; Eisert R; Ganser A
    Vox Sang; 1999; 77 Suppl 1():87-9. PubMed ID: 10529697
    [No Abstract]   [Full Text] [Related]  

  • 57. Lupus anticoagulant: performance of a new, fully automated commercial screening and confirmation assay.
    Montaruli B; Vaccarino A; Foli C; Rus C; Agnes C; Saitta M; Bazzan M
    Clin Chem; 2005 Jun; 51(6):1031-3. PubMed ID: 15914788
    [No Abstract]   [Full Text] [Related]  

  • 58. Detection of the lupus anticoagulant in pregnancy.
    Derksen RH; Out HJ; Blokzijl L; de Groot PG
    Clin Exp Rheumatol; 1992; 10(3):323-4. PubMed ID: 1582083
    [No Abstract]   [Full Text] [Related]  

  • 59. Clot waveform of APTT has abnormal patterns in subjects with COVID-19.
    Shimura T; Kurano M; Kanno Y; Ikeda M; Okamoto K; Jubishi D; Harada S; Okugawa S; Moriya K; Yatomi Y
    Sci Rep; 2021 Mar; 11(1):5190. PubMed ID: 33664450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lupus Anticoagulant-Hypoprothrombinemia syndrome (HLAS): report of one case in a familial infectious context.
    Appert-Flory A; Fischer F; Amiral J; Monpoux F
    Thromb Res; 2010 Aug; 126(2):e139-40. PubMed ID: 20006899
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.